Controlled Ovarian Stimulation Initiated at Different Phases of the Menstrual Cycle for Fertility Preservation in Oncological Patients: a Retrospective Study

被引:1
|
作者
Baig, A. Santolaria [1 ]
Camunas, N. Garcia [1 ]
Sanchez, P. Polo [1 ]
Nadal, J. Subira [1 ,2 ]
Fabuel, S. Monzo [1 ]
Rubio Rubio, J. M. [1 ]
机构
[1] Univ & Polytech La Fe Hosp, Human Reprod Unit, Valencia, Spain
[2] IVIRMA, Valencia, Spain
关键词
Random start; Controlled ovarian stimulation; Fertility preservation; Oncological patients; FORT; FOI; RANDOM-START; BREAST-CANCER; OOCYTE CRYOPRESERVATION; LETROZOLE; PROTOCOLS; WOMEN;
D O I
10.1007/s43032-023-01175-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The purpose of this study is to compare conventional start in early follicular phase (EFP) with late follicular phase (LFP) and luteal phase (LP) in controlled ovarian stimulation (COS) for fertility preservation (FP) to assess differences in clinical outcomes. Retrospective study of the first cycles of COS for FP in oncological patients between 2012 and 2020 in a tertiary hospital. Two-hundred forty-eight cycles were classified into 3 groups: 176 cycles in EFP, 8 cycles in LFP, and 52 cycles in LP. Comparing LFP to EFP, there were no differences in number of oocytes (10.0 [6.3-16.0] vs 12.0 [8.0-18.0]; p = 0.253) or number of metaphase II (MII) obtained (7.0 [2.3-13.3] vs 9.0 [6.0-13.0]; p = 0.229). Total number of days needed was higher in LFP (14.5 [12.5-16.0] vs 3.0 vs 10.0 [8.3-11.0 p = 0.000) but without significant differences in number of days of usage of gonadotropins (11.5 [8.3-12.8] vs 10.0 [8.3-11.0] p = 0.308). No differences were found between LP and EFP in number of oocytes (14.5 [9.0-20.0] p = 0.151) or MII (11.5 [7.0-16.0] p = 0.084). Number of days of gonadotropins (11.0 [10.0-12.0] p = 0.00) and total dosing (3000.0 [2475.0-3600.0] p = 0.013) were significantly higher in LP. FORT and FOI were similar in all groups. COS with a random start in fertility preservation has similar outcomes to EFP start. Therefore, we can initiate COS at any phase of the menstrual cycle with optimal results. However, LP may need more days of stimulation.
引用
收藏
页码:2547 / 2553
页数:7
相关论文
共 50 条
  • [1] Controlled Ovarian Stimulation Initiated at Different Phases of the Menstrual Cycle for Fertility Preservation in Oncological Patients: a Retrospective Study
    A. Santolaria Baig
    N. García Camuñas
    P. Polo Sánchez
    J. Subirá Nadal
    S. Monzó Fabuel
    J. M. Rubio Rubio
    Reproductive Sciences, 2023, 30 : 2547 - 2553
  • [2] Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre
    Sahin, Gulnaz
    Goker, Ege Nazan Tavmergen
    Gokmen, Erhan
    Yeniay, Levent
    Acet, Ferruh
    Zekioglu, Osman
    Tavmergen, Erol
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (03) : 518 - 523
  • [3] Ovarian response to controlled ovarian stimulation for fertility preservation before oncology treatment: A retrospective cohort of 157 patients
    Tsampras, Nikolaos
    Roberts, Stephen A.
    Gould, Della
    Fitzgerald, Cheryl T.
    EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (02)
  • [4] Comparison of Oocyte and Embryo Quality Between Random Start and Controlled Ovarian Stimulation Cycles in Cancer Patients Undergoing Fertility Preservation
    Israfilova, Guler
    Sukur, Yavuz Emre
    Ozkavukcu, Sinan
    Sonmezer, Meltem Aksu
    Atabekoglu, Cem Somer
    ozmen, Batuhan
    Berker, Bulent
    Aytac, Rusen
    Koc, Acar
    Sonmezer, Murat
    REPRODUCTIVE SCIENCES, 2021, 28 (08) : 2200 - 2207
  • [5] Ovarian stimulation for emergency fertility preservation in cancer patients: A case series study
    Rashidi, Batool Hossein
    Tehrani, Ensiyeh Shahrokh
    Ghaffari, Firouzeh
    GYNECOLOGIC ONCOLOGY REPORTS, 2014, 10 : 19 - 21
  • [6] Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients
    Goldrat, O.
    Gervy, C.
    Englert, Y.
    Delbaere, A.
    Demeestere, I.
    HUMAN REPRODUCTION, 2015, 30 (09) : 2184 - 2189
  • [7] Efficacy and safety of controlled ovarian hyperstimulation with or without letrozole for fertility preservation in breast cancer patients: A multicenter retrospective study
    Goldrat, Oranite
    De Cooman, Manon
    Mailliez, Audrey
    Delbaere, Anne
    D'Orazio, Emmanuelle
    Demeestere, Isabelle
    Decanter, Christine
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : 134 - 141
  • [8] Outcomes of ovarian stimulation in the follicular and luteal phases of the menstrual cycle in cancer patients
    Nazarenko, Tatiana A.
    Martirosyan, Yana O.
    Birukova, Almina M.
    Korneeva, Irina E.
    Sokolova, Julia, V
    Khubaeva, Diana G.
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 : 13 - 16
  • [9] Impact of letrozole supplementation during ovarian stimulation for fertility preservation in breast cancer patients
    Sonigo, Charlotte
    Sermondade, Nathalie
    Calvo, Jeremy
    Benard, Julie
    Sifer, Christophe
    Grynberga, Michael
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY-X, 2019, 4
  • [10] Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients
    Andersen, Claus Yding
    Kristensen, Stine Gry
    Greve, Tine
    Schmidt, Kirsten Tryde
    FUTURE ONCOLOGY, 2012, 8 (05) : 595 - 608